A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease. Preliminary pharmacokinetic and safety data after a single intravenous infusion of ...
Burden of cancer in metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results